Insights

Niche Market Focus Capital Biosciences operates as a specialized CRO within the biotechnology research sector, providing high-quality biospecimens and laboratory services tailored for advancing life sciences and medical research, presenting opportunities to collaborate with research institutions and biotech firms seeking ethical and reliable sample sourcing.

Growth Potential With annual revenues ranging from one to ten million dollars and a small, focused team, Capital Biosciences is positioned for scalable growth, especially by expanding its global research partnerships and emphasizing its ethical standards to attract international clients and projects.

Technology Stack The company's use of modern web technologies and secure platforms like reCAPTCHA and Bootstrap indicates a streamlined and professional digital presence, providing opportunities to offer related digital services, platform integrations, or data management solutions to enhance research collaborations.

Market Positioning Operating alongside large biotechnology firms such as QIAGEN and Bio-Rad, Capital Biosciences can capitalize on its niche offerings by emphasizing quality, ethical standards, and customized services to differentiate itself in a competitive landscape and attract partnerships with emerging biotech startups.

Global Partnerships The company's commitment to fostering international collaborations and adherence to strict bioethics policies suggests a strategic opportunity to expand its network, offering tailored biospecimen procurement and research services to global pharma and biotech companies seeking high ethical standards and reliable sample sourcing.

Capital Biosciences Tech Stack

Capital Biosciences uses 8 technology products and services including Google Hosted Libraries, Google Fonts API, jQuery, and more. Explore Capital Biosciences's tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • reCAPTCHA
    Security
  • Bootstrap
    UI Frameworks
  • jQuery Validation Plugin
    Web Tools And Plugins
  • bxSlider
    Web Tools And Plugins

Media & News

Capital Biosciences's Email Address Formats

Capital Biosciences uses at least 2 format(s):
Capital Biosciences Email FormatsExamplePercentage

Frequently Asked Questions

Where is Capital Biosciences's headquarters located?

Minus sign iconPlus sign icon
Capital Biosciences's main headquarters is located at 900 Clopper Road 120 Gaithersburg, Maryland 20878 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Capital Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Capital Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Capital Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Capital Biosciences's official website is capitalbiosciences.com and has social profiles on LinkedIn.

What is Capital Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Capital Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Capital Biosciences have currently?

Minus sign iconPlus sign icon
As of March 2026, Capital Biosciences has approximately 7 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Ceo: G. V.Chief Technology Officer: A. P.Project Manager: F. P.. Explore Capital Biosciences's employee directory with LeadIQ.

What industry does Capital Biosciences belong to?

Minus sign iconPlus sign icon
Capital Biosciences operates in the Biotechnology Research industry.

What technology does Capital Biosciences use?

Minus sign iconPlus sign icon
Capital Biosciences's tech stack includes Google Hosted LibrariesGoogle Fonts APIjQueryPHPreCAPTCHABootstrapjQuery Validation PluginbxSlider.

When was Capital Biosciences founded?

Minus sign iconPlus sign icon
Capital Biosciences was founded in 2006.

Capital Biosciences

Biotechnology ResearchMaryland, United States2-10 Employees

Capital Biosciences Inc. is a biotechnology CRO based out of Gaithersburg, Maryland dedicated to connecting researchers from around the world with clinical sites and repositories of high-quality, clinically annotated tissue specimens, as well as custom cell and molecular biology laboratory services. 

We are committed to fostering global partnerships with the goal of advancing life science research for the benefit of humanity. As the search for new medicines and therapies becomes increasingly paramount, CBI positions itself at the forefront of support for researchers in their efforts to extend and improve the quality of life. 

CBI has defined and adopted strong bioethics policies and has developed state-of-the-art biospecimen procurement procedures to achieve the highest ethical standards in all of its operations. All donors are protected by anonymity and legal Informed Consent documentation stating usage for medical research purposes and possible benefits to scientific discovery and humanity.

Section iconCompany Overview

Headquarters
900 Clopper Road 120 Gaithersburg, Maryland 20878 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Capital Biosciences's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Capital Biosciences's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.